Similar Papers

Paper Title
Journal
Date
Author
Immune-Related Adverse Events and Outcomes in Patients with Advanced Non–Small Cell Lung Cancer: A Predictive Marker of Efficacy?
Jordi Remon ... Benjamin Besse
Journal of Thoracic Oncology | VOL. 14
Jordi Remon, et. al.Jordi Remon ... Benjamin Besse
23 Apr 2019
Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.
Wei Wu ... Trever G Bivona
Journal of Clinical Oncology | VOL. 39
Wei Wu, et. al.Wei Wu ... Trever G Bivona
20 May 2021
Continuous vs. Fixed 2-year Duration Immune Checkpoint Inhibitor Treatment of Patients With Non–Small Cell Lung Cancer: A Single Institution Database Analysis
Haruki Kobayashi ... Toshiaki Takahashi
Clinical Lung Cancer | VOL. 24
Haruki Kobayashi, et. al.Haruki Kobayashi ... Toshiaki Takahashi
15 Jun 2023
A brief report on incidence, radiographic feature and prognostic significance of brain MRI changes after anti-PD-1/PD-L1 therapy in advanced non-small cell lung cancer.
Jianjiao Ni ... Jie Hu
Cancer immunology, immunotherapy : CII | VOL. 71
Jianjiao Ni, et. al.Jianjiao Ni ... Jie Hu
06 Oct 2021
View more papers

More From: ESMO Open

Paper Title
Journal
Date
Author
An open-label, phase IB/II study of abemaciclib with paclitaxel for tumors with CDK4/6 pathway genomic alterations.
K.H Kim ... H.S Kim
ESMO open | VOL. 10
K.H Kim, et. al.K.H Kim ... H.S Kim
01 Feb 2025
Psychiatric disorders in adolescent and young adult cancer survivors in Korea.
S.-M Jeong ... D.W Shin
ESMO open | VOL. 10
S.-M Jeong, et. al.S.-M Jeong ... D.W Shin
01 Feb 2025
Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE).
P.G Casali ... Malvika Vyas
ESMO open | VOL. 10
P.G Casali, et. al.P.G Casali ... Malvika Vyas
01 Feb 2025
HER2DX in HER2-positive inflammatory breast cancer: correlative insights and comparative analysis with noninflammatory breast cancers.
F Lynce ... S.M Tolaney
ESMO open | VOL. 10
F Lynce, et. al.F Lynce ... S.M Tolaney
01 Feb 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.